These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2815254)

  • 1. In vivo mechanisms of alloreactivity. VI. Evidence that alloantigen deposition initiates both local and systemic mechanisms that influence CTL accumulation at a graft site.
    Orosz CG; Bishop DK; Ferguson RM
    Transplantation; 1989 Nov; 48(5):818-24. PubMed ID: 2815254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo mechanisms of alloreactivity. II. Allospecificity of cytotoxic T lymphocytes in sponge matrix allografts as determined by limiting dilution analysis.
    Orosz CG; Zinn NE; Sirinek LP; Ferguson RM
    Transplantation; 1986 Jan; 41(1):84-92. PubMed ID: 2934879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential distribution of antigen-specific helper T cells and cytotoxic T cells after antigenic stimulation in vivo. A functional study using limiting dilution analysis.
    Bishop DK; Ferguson RM; Orosz CG
    J Immunol; 1990 Feb; 144(4):1153-60. PubMed ID: 2137484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo mechanisms of alloreactivity. I. Frequency of donor-reactive cytotoxic T lymphocytes in sponge matrix allografts.
    Orosz CG; Zinn NE; Sirinek L; Ferguson RM
    Transplantation; 1986 Jan; 41(1):75-83. PubMed ID: 2934878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte entry into inflammatory tissues in vivo. Qualitative differences of high endothelial venule-like vessels in sponge matrix allografts vs isografts.
    Bishop DK; Jutila MA; Sedmak DD; Beattie MS; Orosz CG
    J Immunol; 1989 Jun; 142(12):4219-24. PubMed ID: 2470821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 1995 Moyer Award. The effect of burn injury on allograft rejection, alloantigen processing, and cytotoxic T-lymphocyte sensitization.
    Hultman CS; Cairns BA; Yamamoto H; deSerres S; Frelinger JA; Meyer AA
    J Burn Care Rehabil; 1995; 16(6):573-80. PubMed ID: 8582933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a limiting dilution analysis technique that can discriminate in vivo alloactivated cytotoxic T lymphocytes from their naive CTL precursors.
    Orosz CG; Horstemeyer B; Zinn NE; Bishop DK
    Transplantation; 1989 Jan; 47(1):189-94. PubMed ID: 2643226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
    Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
    Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo mechanisms of alloreactivity. III. Development of donor-specific antibody in sponge matrix allografts.
    Sirinek LP; Zinn NE; Ferguson RM; Orosz CG
    Transplantation; 1986 Mar; 41(3):349-56. PubMed ID: 3952801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo mechanisms of alloreactivity. V. Influence of graft implantation on the activation and redistribution of graft-reactive CTL.
    Orosz CG; Horstemeyer B; Zinn NE; Bishop DK; Ferguson RM
    Transplantation; 1989 Sep; 48(3):519-23. PubMed ID: 2675412
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential avidity and cyclosporine sensitivity of committed donor-specific graft-infiltrating cytotoxic T cells and their precursors. Relevance for clinical cardiac graft rejection.
    Vaessen LM; Baan CC; Ouwehand AJ; Balk AH; Jutte NH; Mochtar B; Claas FH; Weimar W
    Transplantation; 1994 Apr; 57(7):1051-9. PubMed ID: 8165702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. III. Epidermal cell-specific cytotoxic T lymphocytes.
    Tyler JD; Steinmuller D
    J Immunol; 1981 May; 126(5):1759-63. PubMed ID: 7012238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limiting dilution analysis for alloreactive, TCGF-secretory T cells. Two related LDA methods that discriminate between unstimulated precursor T cells and in vivo-alloactivated T cells.
    Bishop DK; Orosz CG
    Transplantation; 1989 Apr; 47(4):671-7. PubMed ID: 2523104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size of the donor-reactive CTL pool determined by limiting dilution analysis in sponge matrix allografts.
    Orosz CG; Zinn NE; Sirinek LP; Ferguson RM
    Transplantation; 1986 Mar; 41(3):400-4. PubMed ID: 2869601
    [No Abstract]   [Full Text] [Related]  

  • 15. Early loss of precursors of CTL and IL 2-producing cells in the development of neonatal tolerance to alloantigens.
    Carnaud C; Ishizaka ST; Stutman O
    J Immunol; 1984 Jul; 133(1):45-51. PubMed ID: 6233373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytes capable of mediating delayed-type hypersensitivity reactions accumulate within sponge matrix allografts.
    Ascher NL; Cahill DR; Hoffman RA; Simmons RL
    Surgery; 1986 Aug; 100(2):321-8. PubMed ID: 2943037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity and in vivo correlates of alloantigen-specific murine suppressor T cells induced by allogeneic pregnancy.
    Nagarkatti PS; Clark DA
    J Immunol; 1983 Aug; 131(2):638-43. PubMed ID: 6223087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation of cytotoxic T cells within sponge matrix allografts.
    Ascher NL; Chen S; Hoffman RA; Simmons RL
    J Immunol; 1983 Aug; 131(2):617-21. PubMed ID: 6345671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of human alloantigen-reactive T lymphocytes. III. Evidence that cyclosporine has an inhibitory effect on human CTL and CTL precursors, independent of CsA-mediated helper T cell dysfunction.
    Orosz CG; Adams PW; Ferguson RM
    Transplantation; 1988 Aug; 46(2 Suppl):73S-79S. PubMed ID: 2970141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.